



Endometriosis is a disease that could lead to social problems in women.1 Delay in the diagnosis of endo-
metriosis is not uncommon, even in developed countries. Previous studies in England and USA found that
diagnostic delay could reach 8 and 12 years, respectively.2,3 These delays may occur at the individual level of
women and medical level. At medical level, delay may be caused by the suppression of symptoms due to
intermittent hormonal treatment, failure of physicians to notice menstruation complaints and inadequate
gynecologic examinations.2
Endometriosis is a chronic inflammatory condition associated with defects in immune system. It is clinically
characterized by the presence of endometrial tissue outside the uterine cavity.4,5 Peritoneal fluid in
endometriosis patient contained an increased level of active macrophages secreting various inflammatory
products, including growth factors, cytokines and tumour markers.6 Increase in vascular epithelial
growth factor (VEGF) was known as a mediator of angiogenesis, which enables endometrial cells to proliferate.
Development of endometrial tissue was also caused by various cytokines such as interleukin-6 (IL-6) and
tumour necrosis factor-alpha (TNF-). Furthermore, IL-6, Interleukin-8 (IL-8) and matrix metalloproteinase
(MMP) were also associated with the implantation process of endometrial tissue. Interestingly, increased level
of these cytokines was not only found in peritoneal fluid, but also in the serum of endometriosis patients.7-9
A lot of studies have described the relation between various biological markers and endometriosis diagnosis.
However, IL-6, TNF-, MMP-2, and VEGF were found to have a higher correlation with the incidence of
endometriosis compared to other biological markers.10 Thus, these markers can be a predictor for
diagnosing the early stage of endometriosis if used along side with a combination of clinical symptoms,
signs and other laboratory examination.
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